CB issuance terms amended, dilution 4.63%
차백신연구소
261780
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=2547
Risk-adjusted indicator based on 2547 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Dilution Ratio (Post-amendment): 4.63% of total shares
- • Dilution Ratio (Pre-amendment): 4.43% of total shares
- • Call Option Acquisition Price: 80,000,000 KRW (4% of 2,000,000,000 KRW)
- • Put Option Yield (YTP): 8.0% (annual compound, 3-month basis)
- • Call Option Yield (YTC): 8.0% (annual compound, 3-month basis)
AI Analysis Summary
CHA Vaccine Research Institute has filed an amendment to its convertible bond (CB) issuance, primarily modifying conversion and option terms. The potential dilution from the CB issuance has slightly increased from 4.43% to 4.63% of total shares. The company will pay 80 million KRW for the call option acquisition. Both put and call options offer an 8.0% annual compound yield. The amendment details adjustments to the conversion price, including a floor of 70% of the initial conversion price. This issuance could lead to moderate dilution for existing shareholders, although the specific use of funds is not detailed in this amendment.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.